Sectors
VERA
Vera Therapeutics, Inc.
36.15
1 x 36.09
1 x 36.22
bid
ask
-
1.02
2.73%
01:07 PM
timesize
| Ytd | -28.61% | |
| 1y | 62.20% |
36.14
day range
37.44
19.07
52 week range
56.05
| Open | 36.85 | Prev Close | 37.17 | Low | 36.14 | High | 37.44 | Mkt Cap | 2.67B |
| Vol | 307.88K | Avg Vol | 1.62M | EPS | -5.54 | P/E | -6.71 | Forward P/E | -10.88 |
| Beta | 0.92 | Short Ratio | 7.83 | Inst. Own | 110.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 37.15 | 200-d Avg | 38.78 | 1yr Est | 81.79 |
| Income Statement | |||
| Operating Expenses | 125.13M | ||
| Research and Development Expense | 86.01M | ||
| Selling, General and Administrative Expense | 39.12M | ||
| Operating Income | -125.13M | ||
| Interest Expense | 1.82M | ||
| Net Income | -121.03M | ||
| Net Income Common Stock | -121.03M | ||
| Net Income Common Stock (USD) | -121.03M | ||
| Consolidated Income | -121.03M | ||
| Earnings per Basic Share | -1.69 | ||
| Earnings per Basic Share (USD) | -1.69 | ||
| Earnings per Diluted Share | -1.69 | ||
| Earning Before Interest & Taxes (EBIT) | -119.21M | ||
| Earning Before Interest & Taxes (USD) | -119.21M | ||
| Weighted Average Shares | 71.48M | ||
| Weighted Average Shares Diluted | 71.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 114.35M | ||
| Cash and Equivalents (USD) | 114.35M | ||
| Investments | 482.41M | ||
| Investments Current | 482.41M | ||
| Current Assets | 615.80M | ||
| Total Assets | 621.74M | ||
| Total Debt | 75.03M | ||
| Current Liabilities | 45.15M | ||
| Debt Non-Current | 75.03M | ||
| Total Liabilities | 122.04M | ||
| Accumulated Retained Earnings (Deficit) | -881.90M | ||
| Accumulated Other Comprehensive Income | -156.00K | ||
| Shareholders Equity | 499.70M | ||
| Shareholders Equity (USD) | 499.70M | ||
| Assets Non-Current | 5.94M | ||
| Total Debt (USD) | 75.03M | ||
| Liabilities Non-Current | 76.89M | ||
| Trade and Non-Trade Payables | 13.91M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 256.00K | ||
| Net Cash Flow from Financing | 3.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -240.37M | ||
| Capital Expenditure | -173.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -15.00M | ||
| Issuance (Purchase) of Equity Shares | 3.94M | ||
| Net Cash Flow from Investing | -137.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -122.64M | ||
| Net Cash Flow from Operations | -106.50M | ||
| Share Based Compensation | 13.21M | ||